| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/25/2012 | CN101921266B 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof |
| 07/25/2012 | CN101869623B Medicament for treating trichoepithelioma and preparation method thereof |
| 07/25/2012 | CN101820921B SiRNAs useful for inhibiting expression of tyrosinase gene, the compositions comprising the siRNAs and their uses |
| 07/25/2012 | CN101716219B Use of fragrant cinnamon oil in preparing medicine for burns and scalds |
| 07/25/2012 | CN101711874B Application of cell penetrating peptide Tat-mediated growth factor in transdermal transfer |
| 07/25/2012 | CN101664489B Preparation method of traditional Chinese medical composition as well as quality control method thereof |
| 07/25/2012 | CN101554369B External spraying agent and eye drop of compound oil nano-emulsion as well as preparation method thereof |
| 07/25/2012 | CN101495467B Method for preventing coloration of catechins and dentifrice composition |
| 07/25/2012 | CN101366924B Chinese medicine for wound |
| 07/25/2012 | CN101336714B Cosmetic health-preserving noodle capable of nourishing and activating skin cell and production method thereof |
| 07/24/2012 | US8227620 Pharmaceutical compounds |
| 07/24/2012 | US8227474 Sodium channel blockers |
| 07/24/2012 | US8226994 Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques |
| 07/24/2012 | CA2699454C Methods for inhibiting tgf-.beta. |
| 07/24/2012 | CA2515731C Sunscreen hydroethanolic foam |
| 07/24/2012 | CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/24/2012 | CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/24/2012 | CA2455039C Reduction of hair growth |
| 07/19/2012 | WO2012097052A2 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
| 07/19/2012 | WO2012096463A2 Composition containing a mixed herbal extract as an active ingredient for preventing and improving allergic or non-allergic skin disease, and uses thereof |
| 07/19/2012 | WO2012096257A1 Hair growth stimulant |
| 07/19/2012 | WO2012095719A1 Melatonin and an antimicrobial or antibacterial agent for the treatment of acne |
| 07/19/2012 | WO2012095702A1 A composition for the regeneration of atrophic tissues |
| 07/19/2012 | WO2012064099A3 Aroma composition whereby the fragrance of citrus unshiu of jeju island is reproduced, and composition containing same for external application to the skin |
| 07/19/2012 | WO2012057417A8 Composition containing okamejei kenojei extract |
| 07/19/2012 | WO2011159254A3 The use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases |
| 07/19/2012 | US20120184621 Method for treating phytophotodermatitis |
| 07/19/2012 | US20120184620 Antioxidant composition |
| 07/19/2012 | US20120184619 Composition for promoting collagen production |
| 07/19/2012 | US20120184616 Methods for treating inflammation |
| 07/19/2012 | US20120184612 Compositions and Methods Relating to Carotenoids |
| 07/19/2012 | US20120184608 N alkylcarbonyl amino lactone compounds and their use |
| 07/19/2012 | US20120184597 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
| 07/19/2012 | US20120184593 Laminin-332 production stimulating composition |
| 07/19/2012 | US20120184579 Quinolines and Their Therapeutic Use |
| 07/19/2012 | US20120184575 Topical administration carrier composition and therapeutic formulations comprising same |
| 07/19/2012 | US20120184571 Quinazolinone derivatives useful as vanilloid antagonists |
| 07/19/2012 | US20120184569 A3 adenosine receptor agonists and antagonists |
| 07/19/2012 | US20120184535 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 07/19/2012 | US20120184534 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 07/19/2012 | US20120184524 Pyrazolopyridine kinase inhibitors |
| 07/19/2012 | US20120184523 C-Met Modulators and Method of Use |
| 07/19/2012 | US20120184520 Glycine compound |
| 07/19/2012 | US20120184511 Novel Pharmaceutical Composition Comprising a Macrolide Immunosuppressant Drug |
| 07/19/2012 | US20120184507 Leaven-based mixture |
| 07/19/2012 | US20120184500 Stevia extract or steviol for hair care |
| 07/19/2012 | US20120184493 Dermal formulations of dp2 receptor antagonists |
| 07/19/2012 | US20120184481 Variants of pigment epithelium derived factor and uses thereof |
| 07/19/2012 | US20120183631 Ingredient extracted from pouzolzia zeylanica (l.) benn and its anti-acne formula |
| 07/19/2012 | US20120183630 Compositions and methods for stimulating wound healing |
| 07/19/2012 | US20120183595 Transdermal Pharmaceutical Delivery Composition |
| 07/19/2012 | US20120183584 Method for preparing a stable oil-in-water emulsion |
| 07/19/2012 | US20120183579 Compounds for inflammation and immune-related uses |
| 07/19/2012 | US20120183565 Fully human antibodies to btla |
| 07/19/2012 | US20120183564 Inhibition of endosomal toll-like receptor activation |
| 07/19/2012 | US20120183562 Secreted fxyd proteins expressed in response to epithelial tissue damage, and uses therefor |
| 07/19/2012 | US20120183558 Antibody molecules which bind il-17a and il-17f |
| 07/19/2012 | US20120183543 Diagnostic biomarkers for fibrotic disorders |
| 07/19/2012 | US20120183541 Hair growth methods using fgfr4 extracellular domains |
| 07/19/2012 | US20120183538 Sparc antisense compositions and uses thereof |
| 07/19/2012 | US20120183510 High-throughput culture and transfer device and method |
| 07/19/2012 | US20120183501 Novel method for treatment of skin wounds and preparations for implementation of same |
| 07/19/2012 | US20120183493 Novel polymers |
| 07/19/2012 | US20120183481 Heparanase activity inhibitor |
| 07/19/2012 | US20120181201 Topical Formulation Containing a Tetracycline and a Method of Treating Skin Infections Using the Same |
| 07/19/2012 | CA2824706A1 Pharmaceutical compositions for the treatment of parasitic diseases, cancer, or skin diseases by topical administration |
| 07/19/2012 | CA2824175A1 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
| 07/19/2012 | CA2824151A1 Antigen surrogates in autoimmune disease |
| 07/19/2012 | CA2823689A1 Methods for accelerating the healing of connective tissue injuries and disorders |
| 07/18/2012 | EP2476421A1 Hyaluronic acid based mucoadhesive therapeutic composition for the prevention and treatment of epithelial and mucosal lesions of the human body |
| 07/18/2012 | EP2476408A1 External preparation containing pantethine phosphate ester |
| 07/18/2012 | EP2475681A1 Plgf-1 in homodimeric form |
| 07/18/2012 | EP2475647A1 Androgen receptor antagonists and uses thereof |
| 07/18/2012 | EP2475388A1 Use of il-33 antagonists to treat fibrotic disease |
| 07/18/2012 | EP2475387A1 Use of vap-1 inhibitors for treating fibrotic conditions |
| 07/18/2012 | EP2475371A1 Pharmaceutical composition comprising a3 adenosine receptor agonist (ib-meca/cf-101) for treatment of psoriasis |
| 07/18/2012 | EP2475369A1 Use of steroid compounds for inflammatory and autoimmune disorders |
| 07/18/2012 | EP2283022B1 Furo [3, 2-b]pyrr0l-3-0nes as cathepsin s inhibitors |
| 07/18/2012 | EP1470148B1 Double-stranded oligonucleotides |
| 07/18/2012 | EP1435999B1 Combination of two bioactive regions of pro-opiomelanocortin hormone |
| 07/18/2012 | EP1432735B1 Antagonistic anti-htnfsf13b human antibodies |
| 07/18/2012 | EP1389909B1 Antimicrobial compounds and methods for their use |
| 07/18/2012 | CN1935260B Human antibodies that bind human tnfalpha |
| 07/18/2012 | CN1903214B Ointment containing red precipitate |
| 07/18/2012 | CN1883614B Formulation of hair-blackening tonic and preparation method thereof |
| 07/18/2012 | CN1794983B Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 07/18/2012 | CN1774448B Growth factor complexes and modulation of cell migration and growth |
| 07/18/2012 | CN1738636B Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 07/18/2012 | CN1639130B Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/18/2012 | CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 07/18/2012 | CN102596990A PLGF-1 in homodimeric form |
| 07/18/2012 | CN102596949A 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 07/18/2012 | CN102596917A Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate |
| 07/18/2012 | CN102596205A Use of non-digestible oligosaccharides |
| 07/18/2012 | CN102596193A Dermal formulations of DP2 receptor antagonists |
| 07/18/2012 | CN102596187A Carbohydrate entrapped active agent delivery composition and articles using the same |
| 07/18/2012 | CN102596165A External preparation containing pantethine phosphate ester |
| 07/18/2012 | CN102586177A Culture method of hair follicle stem cell for treating baldness, as well as syringe |
| 07/18/2012 | CN102586045A Process for making bamboo leaf beautifying wine |